NPI registry status
Active
2026 NPPES data Nephrology Physician NPI 1407893290 M.D.
Verify on CMS → Fadi Bedros, M.D.
Nephrology Physician in Manhattan, Kansas.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 10,806 in Nephrology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
2K
Medicare Part D claims · 361 beneficiaries · Nephrology Physician avg: 2K
Generic prescribing
86%
generic claims · 14% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
11.6/100
▼ 72 pts below national avg 83.5 · Penalty band
Industry payments
$340.86
5 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Fadi Bedros, M.D. reported a CMS MIPS final score of 11.6/100 - below the 83.5 national average - and filed 2,066 Medicare Part D claims in 2024.
- 11.6/100
- MIPS score · -72 vs avg
- 2K
- Part D claims, 2024
- 86%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Fadi Bedros, M.D.
Federal records show an active NPI with both Medicare prescribing volume and a measured CMS quality score — objective registry data, not patient reviews.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1407893290), first enumerated 06/01/2006.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 2,066 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
CMS quality reporting (MIPS)
Reported a CMS MIPS final score of 11.6/100 in the Quality Payment Program — a federal quality measure, not a patient review.
Source: CMS Quality Payment Program
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Hospital affiliations
1 CMS Care Compare hospital affiliation on record — practice footprint from the Doctors and Clinicians file.
Source: CMS Care Compare
- Reported
Industry payment transparency
$340.86 in reported industry payments (5 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1407893290 · Nephrology Physician
NPI-10 · ENUM-LEGACY · TAX-MID · MIPS-LOW · RX-MID · BOOK-THIN · PHOTO-FINISH
- NPI-10 1407893290
- ENUM-LEGACY 2006
- TAX-MID 11K Nephrology Physician
- MIPS-LOW 11.6/100
- RX-MID 2,066
- BOOK-THIN 59 in Kansas
- PHOTO-FINISH Manmeet Brar, MD · ±0.0
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Subramaniam Anan…
Subramaniam Anandasivam, MD PA
11.5 MIPS pts
- Lawrence Stam, M…
Lawrence Stam, M.D.
11.5 MIPS pts
- Bedros · this pr…
Bedros · this provider
11.6 MIPS pts
- Manmeet Brar, MD…
Manmeet Brar, MD
11.6 MIPS pts
- Raju Patil, M.D.…
Raju Patil, M.D., M.P.H.
11.7 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
Fadi Bedros, M.D.'s MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
12 ≥ 2nd percentile 2% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Fadi Bedros, M.D. sits
This provider among nephrology physician peers
Across the 2,230 nephrology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Fadi Bedros, M.D. writes more Part D claims than 77% of them and scores higher on MIPS quality than 3% - placing this provider in the high-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one nephrology physician peer from a representative sample of 60; the gold marker is Fadi Bedros, M.D.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Fadi Bedros, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Fadi Bedros, M.D.?
Below national averagePrimary specialty
Nephrology Physician
Medicare Part D claims
2,066 37% vs specialty avg
MIPS final score
11.6/100 71.9 pts vs avg
Specialty distribution in Kansas
How Nephrology Physician compares to other specialties among Kansas providers
Medicare quality performance, MIPS
Fadi Bedros, M.D.'s 2023 MIPS final score plotted against the Nephrology Physician national average
- MIPS Final Score
- 11.6/100
- vs 83.5 national avg · 2023 performance year
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1407893290 |
|---|---|
| Specialty | Nephrology Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 06/01/2006 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
11.5669
Final Score
Measured-score avg: 83.5
0
Quality
38.5563
Cost
Reporting: Individual
Hospital and facility affiliations
Facilities where Fadi Bedros, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
MY Kidney Center LLC
Manhattan, KS
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Fadi Bedros, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$341
Largest payer
Travere Therapeutics, Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Typical
Fadi Bedros, M.D. - brand share 14.0%
Nephrology Physician average
14% brand-name claims vs 86% generic, on 2,066 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
2,066
Total Claims
$150K
Total Drug Cost
361
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 4,046.8
- Total Day Supply
- 117,114
- Brand vs Generic
- 14% brand / 86% generic
- Brand Drug Cost
- $128K
- Generic Drug Cost
- $21K
- Antibiotic Claims
- 14
Patient Demographics
- Average Patient Age
- 73.3 years
- Avg HCC Risk Score
- 2.93
- Gender Split
- 52% female / 48% male
- Age Distribution
- <65: 52, 65-74: 150, 75-84: 108, 85+: 51
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Fadi Bedros, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2024
- Furosemide
Furosemide
203 claims
- Lisinopril
Lisinopril
182 claims
- Amlodipine Besylate
Amlodipine Besylate
165 claims
- Allopurinol
Allopurinol
139 claims
- Losartan Potassium
Losartan Potassium
117 claims
- Calcitriol
Calcitriol
91 claims
- Farxiga
Farxiga
91 claims
- Hydralazine Hcl
Hydralazine Hcl
82 claims
| Drug | Claims |
|---|---|
| Furosemide | 203 |
| Lisinopril | 182 |
| Amlodipine Besylate | 165 |
| Allopurinol | 139 |
| Losartan Potassium | 117 |
| Calcitriol | 91 |
| Farxiga Dapagliflozin Propanediol | 91 |
| Hydralazine Hcl | 82 |
| Metolazone | 67 |
| Tamsulosin Hcl | 65 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Nephrology Physician Overview
How Fadi Bedros, M.D. fits within the Nephrology Physician landscape nationally.
10,806
Nephrology Physician Providers in US
55
States with Nephrology Physician
1,511
Avg Claims per Provider
Fadi Bedros, M.D.'s 2,066 claims are above the specialty average of 1,511.
Nationwide Nephrology Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Bedros, both outside Kansas so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (11.6 here).
Same NPPES enumeration year (2006)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Nephrology Physician Providers in Kansas
Other clinicians with the same primary specialty enrolled in Kansas, drawn from the same CMS NPPES roster as Bedros.
One of 59 Nephrology Physician providers enrolled in Kansas, 5 are shown here.
Emmanuel Adomako
MB, CHB
Kansas City, KS
Dr. Ahmad Al Masry
MD
Wichita, KS
Dr. Thomas Alderson
MD
Topeka, KS
Dr. Brenden Amiotte
MD
Kansas City, KS
Dr. Dennis Artzer
MD
Topeka, KS
Compare Nephrology Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Fadi Bedros, M.D.'s specialty? ▼
Fadi Bedros, M.D. specializes in Nephrology Physician and practices in Manhattan, Kansas. Credentials: M.D..
How much does Fadi Bedros, M.D. prescribe under Medicare Part D? ▼
In 2024, Fadi Bedros, M.D. wrote 2,066 Medicare Part D claims totaling $150K in drug costs for 361 beneficiaries.
What is Fadi Bedros, M.D.'s Medicare quality score? ▼
Fadi Bedros, M.D. has a CMS MIPS Final Score of 11.6/100 (Quality: 0, Cost: 38.6). The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Fadi Bedros, M.D. located? ▼
Fadi Bedros, M.D. is located at 1133 COLLEGE AVE, Manhattan, KS, 66502. Phone: (785) 565-9500.
What is Fadi Bedros, M.D.'s NPI number? ▼
Fadi Bedros, M.D.'s National Provider Identifier (NPI) is 1407893290, issued on 06/01/2006.
Does Fadi Bedros, M.D. prescribe more brand-name or generic drugs? ▼
Fadi Bedros, M.D.'s prescribing is 14% brand-name and 86% generic drugs by claim count, with $128K in brand drug costs.
How many Nephrology Physician providers are there in the US? ▼
There are 10,806 Nephrology Physician providers across 55 states in the US. The average Nephrology Physician provider writes 1,511 Medicare Part D claims per year.
What drugs does Fadi Bedros, M.D. prescribe most often? ▼
Based on 2024 Medicare Part D data, Fadi Bedros, M.D.'s most frequently prescribed drugs include Furosemide, Lisinopril, Amlodipine Besylate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Fadi Bedros, M.D. accept Medicare? ▼
Fadi Bedros, M.D. appears in CMS Medicare data with 2,066 Part D claims and 361 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Fadi Bedros, M.D.'s credentials? ▼
Fadi Bedros, M.D.'s NPI is 1407893290 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.